Related Experiment Video
Updated: Aug 2, 2025
12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.8K
α-synuclein seed amplification and its uses in Parkinson's disease
Daniela Berg1, Christine Klein2
1Department of Neurology, Christian Albrechts-University and University Hospital Schleswig-Holstein (Campus Kiel), Kiel, Germany.
The Lancet. Neurology
|April 14, 2023
Abstract
No abstract available in PubMed .
Related Concept Videos
01:15Parkinson's Disease: Overview
628
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
628
01:37Neural Regulation
39.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.6K